Sorin Group Announces US Market Clearance for Stockert S5 Heart-Lung Machine; New, Modular Perfusion System Offers Better Safety and Standard of Care for Hospitals

Sorin Group (MIL:SRN), worldwide leader in cardiac
surgery solutions, released also in the US the successor to Sorin
Group's SIII perfusion system-the S5. The Stockert S5 is a
fifth-generation heart-lung machine (HLM), coming from Stockert and
COBE Cardiovascular brand technologies and is expected to help
hospitals achieve new industry standards for safety, functionality,
flexibility and quality. U.S. cardiac surgery teams now have access to
the S5 along with the Stockert Heater-Cooler System 3T, used to
control patient's temperature during cardiac surgery and also recently
cleared for sale in the United States.
"The Stockert S5 represents a quantum leap in perfusion technology
and the culmination of more than 30 years of experience in
extracorporeal perfusion system design and manufacturing" said Jim
Trevor, Country Manager, USA Commercial Operations and Vice President
of Sales and Marketing, PBMS.
Significant advances have been made with this system in the area
of patient safety. For example, the smaller footprint of the S5 allows
closer positioning of the unit to the patient, effectively reducing
line lengths and the possibility of hemodilution. In addition,
acoustically differentiated alarms and information displayed on the
high-resolution touch screens clearly describe the status of all
monitoring functions of the extracorporeal circuit. Further, with the
Stockert S5, there is no boot-up time, so the pumps are operable three
seconds after turning the system on, which is important in emergency
situations.
"The S5 does not use PC-based technology to control the system.
All modules are directly programmed to perform a perfusion specific
function and are completely interchangeable", commented Dr. Andreas
Hahn, senior vice president, Business Line - Heart-Lung Machines.
"When you combine the advanced features, ergonomics, functionality and
quality of this system, it is clear that we've taken an important leap
with the Stockert S5."
"Sorin Group collaborated with perfusionists across the globe to
ensure that our newest heart-lung machine would include the most
advanced features and technology," added Hahn, "and we are also
excited to launch our triple channel heater cooler system in the U.S.
market."
During bypass, the Stockert Heater-Cooler System 3T controls the
temperature of the patient while separately controlling the
temperature of the heart using independent water baths that are
controlled by an extremely quiet and effective compressor system.
Drago Cerchiari, CEO for Sorin Group said the Stockert S5 is part
of a company-wide strategy to maintain its market leadership position
in the U.S. perfusion and blood management markets. "With the
introduction of the PrimO2x low prime adult oxygenator earlier this
year, the Stockert heater-cooler system 3T and now the Stockert S5
heart lung machine, Sorin Group has taken product innovation and
patient safety to a new level".

About Sorin Group

Sorin Group (Reuters code: SORN.MI), a world leader in the
development of medical technologies for cardiac surgery, offers
innovative therapies for cardiac rhythm dysfunctions, interventional
cardiology and the treatment of chronic kidney diseases. The companies
of Sorin Group are: Bellco, CarboMedics, COBE Cardiovascular, Dideco,
ELA Medical, Mitroflow, Soludia, Sorin Biomedica and, Stockert. Sorin
Group has about 4,800 employees working at facilities in more than 80
countries throughout the world to serve over 5,000 public and private
treatment centers.
For additional information, please visit our website:
www.sorin.com